According to Travere Therapeutics's latest financial reports the company's total assets are $0.78 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.78 B | 17.3% |
2022-12-31 | $0.67 B | -13.4% |
2021-12-31 | $0.77 B | 27.85% |
2020-12-31 | $0.60 B | 0.44% |
2019-12-31 | $0.60 B | -14.72% |
2018-12-31 | $0.70 B | 36.29% |
2017-12-31 | $0.52 B | -0.94% |
2016-12-31 | $0.52 B | 2.54% |
2015-12-31 | $0.51 B | 278.14% |
2014-12-31 | $0.13 B | 560.87% |
2013-12-31 | $20.49 M | 757.24% |
2012-12-31 | $2.39 M | |
2012-02-29 | $0 M | |
2011-02-28 | $0 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | 155.00% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $22.68 M | -97.12% | ๐บ๐ธ USA |